about
Arid5a regulates naive CD4+ T cell fate through selective stabilization of Stat3 mRNA.IL-21R signaling is critical for induction of spontaneous experimental autoimmune encephalomyelitis.Secukinumab (AIN-457) for the treatment of Psoriasis.Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors.Proteasome inhibition suppresses Th17 cell generation and ameliorates autoimmune development in experimental Sjögren's syndrome.From RORγt Agonist to Two Types of RORγt Inverse Agonists.Th17 cell-derived IL-17A promoted tumor progression via STAT3/NF-κB/Notch1 signaling in non-small cell lung cancerTh17 response in patients with cervical cancer
P2860
Q29465540-FDD610B7-0217-4BB1-BBD9-07AD88FEDCB8Q36266451-77478132-785C-468F-89DB-425737CF01D9Q38662868-5A0B4263-D083-44D2-976F-630DD815169CQ41108727-7D787F73-0C81-478C-95F2-A8EF7A55CDC2Q48727596-9B1872E7-413F-4039-BAAC-2D2AB607EC69Q49874370-86133DA9-A889-428C-8869-A41EC2C76255Q58129687-670F7E87-0815-4F6E-B0DC-E37456558566Q58572928-F32AEE80-633D-4508-A6F3-C43FD6F79267
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Targeting Th17 cells in immune diseases.
@en
type
label
Targeting Th17 cells in immune diseases.
@en
prefLabel
Targeting Th17 cells in immune diseases.
@en
P2860
P356
P1433
P1476
Targeting Th17 cells in immune diseases.
@en
P2093
P2860
P2888
P304
P356
10.1038/CR.2014.92
P577
2014-07-15T00:00:00Z
P5875
P6179
1052462604